Eurasia Group’s Aditya Bhattacharji tackles three more key geopolitical issues that global pharma needs to be cognizant of: the world’s leading drug regulators becoming increasingly strident and active beyond national…
With a relatively high number of genetic disorders, the Arab population of the United Arab Emirates (UAE) is increasingly becoming the subject of new studies. The database from the Center…
Over the last 22 years, Jorge Rodríguez has grown Puerto Rican industrial automation solutions provider PACIV from a one-man show to an international operator with over 100 employees. Jorge…
Headquartered in Tampa, Florida, Romark focuses on developing innovative treatments for infectious diseases and the latest newcomer to Puerto Rico. CEO Marc Ayers recounts how he came to the decision…
Ai Hua Ong, Asia-Pacific company group chairman of Janssen, the Pharmaceutical Companies of Johnson & Johnson, looks back at the tremendous progress the pharmaceutical industry has made in the Asia-Pacific…
Boston University School of Law’s Kevin Outterson* looks at how cost-saving measures are contributing to the rise of drug-resistant “superbugs” in the US and the steps that need to be…
Monica Weldon, CEO and president of Bridge the Gap – SYNGAP Education and Research Foundation, shares her recent experience at the US Drug Law and Regulation course in Washington, DC…
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of geopolitical and bureaucratic issues are restricting the flow of…
The Czech Republic’s Minister of Health, Adam Vojtěch, is the youngest in the country’s history and has set out an ambitious reform programme to improve the state of the Czech…
Sweden is fast staking a claim as one of Europe’s premier biotech hotspots thanks to a holistic approach to research projects, a strong institutional ecosystem, and increasingly easy access to…
Since going public five years ago, Recipharm, Sweden’s iconic indigenous contract development and manufacturing organization (CDMO), has seen its sales skyrocket by over 30 percent annually. Much of this growth…
Key stakeholders in Swedish pharma explain why Sweden’s record on cancer care is the best in Europe and what more still needs to be done. National investments in cancer…
See our Cookie Privacy Policy Here